MUC1 and autosomal dominant medullary cystic kidney disease with or without hyperuricemia: Since (a) no treatments are currently available for this disease, and (b) ADTKD-UMOD and ADTKD-MUC1 appear to share TMEDs as a common, nodal biological pathway underlying both diseases, our study provides the rationale for deployment of this therapeutic strategy to both patient populations.